Specialty Vision is an online directory, not a healthcare provider. Listed practices are not owned or operated by us.

Specialty Vision is an online directory and does not provide healthcare services. Listed practices and doctors are not owned, operated, or employed by Specialty Vision.

North Carolina Macular Dystrophy: Causes, Diagnosis, and Prognosis

Understanding North Carolina Macular Dystrophy

Understanding North Carolina Macular Dystrophy

North Carolina macular dystrophy is an autosomal dominant condition that affects macular development. It was first described in a large family from the Appalachian region of North Carolina, from which the condition takes its name. The condition has since been identified in families of diverse ethnic backgrounds around the world. At least 30 North Carolina macular dystrophy pedigrees from different ethnicities have been genetically identified worldwide (EyeWiki, 2024). The defining characteristic of North Carolina macular dystrophy is that it is considered a congenital macular malformation rather than a progressive dystrophy, meaning the macular changes develop during fetal retinal development and do not worsen substantially over the course of a lifetime.

North Carolina macular dystrophy is caused by genetic variants that affect the regulation of the PRDM13 gene on chromosome 6, a locus designated MCDR1. The PRDM13 gene encodes a transcription factor that is expressed in the developing neural retina, where it plays a role in the normal formation of retinal cell types including amacrine cells. The disease-causing variants are located in noncoding DNA upstream of the PRDM13 gene, where they alter a regulatory region that controls when and where the gene is active. This dysregulation during fetal development leads to abnormal formation of the macular region. A second genetic locus, MCDR3, located on chromosome 5 near the IRX1 gene, has also been identified as a cause of the condition in some families.

Most macular dystrophies involve progressive degeneration of the retinal tissue over time, leading to worsening vision as a person ages. North Carolina macular dystrophy is distinct because the macular abnormality forms during retinal development and then remains largely stable. Similar visual acuity in three generations of patients supports the observation that North Carolina macular dystrophy is not a progressive disorder (Ophthalmology Retina, 2022). This nonprogressive nature provides a more favorable long-term visual prognosis compared to most other inherited macular conditions. However, some patients may experience late complications such as choroidal neovascularization that can cause additional vision changes.

Who Is Affected

North Carolina macular dystrophy follows an autosomal dominant inheritance pattern, meaning that a person needs to inherit only one copy of the genetic variant from either parent to be affected. The condition is fully penetrant, meaning everyone who carries the pathogenic variant develops macular changes, though the severity varies considerably from person to person. Males and females are equally affected. Each child of an affected parent has an equal chance of inheriting or not inheriting the variant.

North Carolina macular dystrophy is rare, though exact prevalence figures are not well established. The condition was originally identified in a large family in the southern Appalachian mountains of North Carolina, and many affected families in the United States trace their ancestry to this region. However, the condition has been found in numerous families across the United States, Europe, Central America, Australia, New Zealand, South Korea, and China, demonstrating that it occurs worldwide and is not limited to any single population.

Because North Carolina macular dystrophy is a congenital condition, the macular changes are present from birth. However, the condition is often not detected until a routine eye examination reveals the macular abnormality or until reduced visual acuity is noticed during childhood vision screening. In families with a known history of the condition, affected children may be identified through targeted examination at an early age. The nonprogressive nature of the condition means that the macular appearance found at the time of diagnosis generally reflects the long-term state of the macula.

Signs and Symptoms

The visual acuity in North Carolina macular dystrophy varies widely depending on the severity of the macular involvement. Visual acuity in North Carolina macular dystrophy ranges from 20/20 to 20/400 with a median of 20/60 (EyeWiki, 2024). Patients with mild macular changes (grade 1) may have normal or near-normal vision, while those with larger macular lesions (grade 3) typically have more significant visual impairment. The visual acuity generally remains stable throughout life, which distinguishes this condition from progressive macular dystrophies where vision gradually declines.

North Carolina macular dystrophy is classified into three grades based on the severity of the macular findings. Grade 1 is characterized by scattered, small drusen-like deposits in the macular region that may be visually insignificant. Grade 2 features confluent drusen-like deposits or central vitelliform-like lesions that can affect visual acuity. Grade 3 presents with large, excavated, coloboma-like chorioretinal macular lesions called calderas, which represent the most severe form. The grade of involvement tends to be consistent throughout a patient's life, though different members of the same family may have different grades.

The macular caldera is a distinctive feature of North Carolina macular dystrophy. A caldera is a large, well-defined, excavated lesion at the macula where the retinal and choroidal layers are deeply thinned or absent. On optical coherence tomography, calderas show loss of the inner retinal layers with excavation extending through multiple retinal layers. These calderas are unique to North Carolina macular dystrophy and are seen in an age-independent manner, meaning they are present in both young and old affected individuals. The caldera represents the most severe grade of the condition but is a developmental finding rather than the result of progressive tissue loss.

North Carolina macular dystrophy characteristically affects both eyes in a symmetric fashion. The macular findings in the right and left eyes of an affected individual are generally similar in grade and appearance. This bilateral symmetry is consistent with the developmental nature of the condition, as both eyes undergo the same developmental process and are affected by the same genetic dysregulation during fetal retinal formation.

Diagnosis and Testing

A comprehensive dilated eye examination reveals the characteristic macular findings of North Carolina macular dystrophy. The retinal specialist will observe the macular changes and classify them according to the grading system. The bilateral, symmetric nature of the findings and the stability of the macular appearance over time support the diagnosis. The clinical appearance can sometimes be confused with other macular conditions, making it important to consider North Carolina macular dystrophy in the differential diagnosis, particularly when macular changes are found in a young patient with a family history of macular disease.

Optical coherence tomography is particularly valuable in North Carolina macular dystrophy, as it provides detailed cross-sectional images of the retinal layers that reveal the structural features of the condition. In grade 3 disease, OCT shows the characteristic caldera with excavation and loss of inner retinal layers. Fundus autofluorescence imaging maps the extent of retinal pigment epithelium changes and helps characterize the borders of the macular lesions. These imaging studies help establish the grade of the condition and provide a baseline for monitoring.

Genetic testing can confirm the diagnosis by identifying the pathogenic variant at the MCDR1 locus near the PRDM13 gene or at the MCDR3 locus near the IRX1 gene. Because the causative variants are in noncoding regulatory regions rather than within the coding sequence of a gene, specialized testing approaches may be needed. Genetic confirmation is valuable for distinguishing North Carolina macular dystrophy from other macular conditions, for family screening, and for genetic counseling. Testing can also identify the specific genetic locus involved, which contributes to the growing understanding of genotype-phenotype correlations in this condition.

Full-field electroretinography is typically normal in North Carolina macular dystrophy because the condition is confined to the macula and does not affect the peripheral retina. Multifocal electroretinography, which measures the function of the central retina in more detail, may show reduced responses in the macular region corresponding to the areas of structural abnormality. The normal full-field electroretinography helps distinguish North Carolina macular dystrophy from more widespread retinal dystrophies that affect both the macula and the peripheral retina.

Possible Complications

Although North Carolina macular dystrophy itself is nonprogressive, some patients develop choroidal neovascularization as a secondary complication. This involves the growth of abnormal blood vessels from the choroid through the damaged macular tissue, which can leak fluid and blood and cause sudden worsening of vision. Choroidal neovascularization can occur at any age in affected patients and represents the primary cause of visual acuity decline in patients who experience worsening vision over time. Patients should be aware of the symptoms of choroidal neovascularization, including new distortion of vision or a sudden decrease in visual acuity.

Some children with North Carolina macular dystrophy develop strabismus, a misalignment of the eyes, particularly when central visual acuity is significantly reduced. The strabismus may result from the reduced macular function interfering with the normal development of binocular vision during childhood. Evaluation and treatment by a pediatric ophthalmologist may be recommended for affected children with strabismus.

Treatment and Management

Because North Carolina macular dystrophy is nonprogressive in most cases, many patients do not require active treatment for the underlying macular condition. Regular monitoring with retinal examinations and imaging is recommended to confirm the stability of the macular findings, establish a baseline for comparison, and detect any secondary complications such as choroidal neovascularization. The frequency of monitoring visits depends on the severity of the macular involvement and the patient's overall visual status.

When choroidal neovascularization develops as a complication of North Carolina macular dystrophy, anti-VEGF intravitreal injections are the standard treatment. These medications block the growth factor that drives the abnormal blood vessels, helping to reduce leakage and preserve vision. Anti-VEGF treatment has been shown to work well for managing choroidal neovascular membranes in patients with North Carolina macular dystrophy. Prompt detection and treatment of neovascularization is important for achieving the best visual outcomes.

Refractive correction with glasses or contact lenses is important for optimizing visual function in patients with North Carolina macular dystrophy, particularly those who have associated refractive errors. For patients with more significant visual impairment from grade 3 macular involvement, low vision rehabilitation services provide magnification devices, electronic reading aids, and strategies for maximizing remaining vision. Educational accommodations may be needed for school-age children with reduced visual acuity.

Genetic counseling is an important component of management for families affected by North Carolina macular dystrophy. Counseling helps family members understand the autosomal dominant inheritance pattern, the implications of full penetrance with variable expressivity, and the options for family screening. Because the condition is congenital and nonprogressive with generally favorable visual outcomes compared to most inherited macular diseases, genetic counseling can provide meaningful reassurance to affected families, particularly parents of newly diagnosed children.

When to See a Retina Specialist

Any child or adult found to have macular changes on routine eye examination should be evaluated by a retina specialist to determine the cause. If the clinical findings are consistent with North Carolina macular dystrophy, genetic testing and family screening can confirm the diagnosis and provide prognostic information. Early diagnosis allows for appropriate counseling and monitoring.

Patients with known North Carolina macular dystrophy should seek prompt evaluation if they experience any sudden change in vision, new distortion of straight lines, or a new dark spot in their central vision. These symptoms may indicate the development of choroidal neovascularization, which requires timely treatment with anti-VEGF injections to preserve visual function.

First-degree relatives of patients with North Carolina macular dystrophy should be offered retinal evaluation and consideration of genetic testing. Because the condition is autosomal dominant and fully penetrant, screening can identify affected family members who may not yet be aware of their macular changes. Identification of affected individuals allows for appropriate monitoring and early detection of any complications.

Questions and Answers

North Carolina macular dystrophy is a rare inherited condition that affects the development of the macula. It is caused by dysregulation of the PRDM13 gene and is considered a congenital macular malformation rather than a progressive dystrophy. The macular changes are present from birth and tend to remain stable over time, which generally provides a more favorable visual prognosis than most other inherited macular conditions.

In most patients, the visual acuity remains stable throughout life because the condition is nonprogressive. Studies following patients across multiple generations have confirmed stable vision over decades. However, some patients can develop choroidal neovascularization, a complication involving abnormal blood vessel growth, which can cause additional vision loss if not treated promptly.

North Carolina macular dystrophy is a congenital condition caused by a single genetic variant that affects macular development before birth. Age-related macular degeneration is a progressive condition that develops in older adults due to a combination of genetic and environmental risk factors. While both conditions can involve drusen-like deposits and choroidal neovascularization, North Carolina macular dystrophy is present from birth and is generally stable, whereas age-related macular degeneration progresses over time.

Because North Carolina macular dystrophy follows an autosomal dominant inheritance pattern with full penetrance, children of an affected parent should be offered retinal evaluation. Genetic testing can confirm whether the child carries the pathogenic variant. Early identification allows for appropriate monitoring and educational support if visual acuity is reduced.

Specialty Vision
Privacy Overview